Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome
- 1 May 1981
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 101 (5), 600-612
- https://doi.org/10.1016/0002-8703(81)90227-1
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.Circulation, 1980
- The preexcitation syndromesProgress in Cardiovascular Diseases, 1978
- Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.Heart, 1977
- The role of an accessory atrioventricular pathway in reciprocal tachycardia. Observations in patients with and without the Wolff-Parkinson-White syndrome.Circulation, 1975
- The effect of Verapamil on the cardiac conduction system in manPublished by Oxford University Press (OUP) ,1974
- Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.Heart, 1974
- Action of verapamil on sinus node, atrioventricular, and intraventricular conduction.Heart, 1973
- Immediate Effects of Intravenous Verapamil in Cardiac ArrhythmiasBMJ, 1972
- The mechanism of production of short P-R intervals and prolonged QRS complexes in patients with presumably undamaged hearts: Hypothesis of an accessory pathway of auriculoventricular conduction (bundle of kent)American Heart Journal, 1933
- Bundle-branch block with short P-R interval in healthy young people prone to paroxysmal tachycardiaAmerican Heart Journal, 1930